Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume III

• Xuejing Zhao,
• Xuejing Zhao,
• Naoe Taira Nihira,
• Xiangpeng Dai,
• Xiangpeng Dai,
• Zichuan Liu,
• Zichuan Liu

Affiliations

Xuejing Zhao

School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China

Xuejing Zhao

Tianjin University and Health-Biotech United Group Joint Laboratory of Innovative Drug Development and Translational Medicine, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China

Naoe Taira Nihira

Department of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan

Xiangpeng Dai

Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China

Xiangpeng Dai

National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital of Jilin University, Changchun, China

Zichuan Liu

School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China

Zichuan Liu

Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin University, Tianjin, China